Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations.

Blood cancer journal·2026

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome.

Cancer·2026

Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Blood cancer discovery·2026

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Blood advances·2026

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Leukemia & lymphoma·2026

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Leukemia & lymphoma·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Leukemia & lymphoma·2026

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Leukemia & lymphoma·2026

Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.

Leukemia & lymphoma·2026

Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients.

Frontiers in immunology·2026

CNS Tuberculoma in a Patient of Acute Lymphoblastic Leukemia: A Rare Case Report.

International journal of hematology-oncology and stem cell research·2026

AuPt bimetallic nanocatalyst-amplified luminol-dissolved oxygen electrochemiluminescence for interferon-γ immunosensing.

Frontiers in chemistry·2026

Mucosal regulatory and effector T-cell imbalance in CVID-associated enteropathy.

Frontiers in immunology·2026

Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling.

Frontiers in immunology·2026

What a negative trial does not tell us: Bayesian reanalysis of the enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients randomized clinical trial.

Clinical nutrition ESPEN·2026

Related Experiment Videos

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'

Related Concept Videos

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations.

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome.

Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.

Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients.

CNS Tuberculoma in a Patient of Acute Lymphoblastic Leukemia: A Rare Case Report.

AuPt bimetallic nanocatalyst-amplified luminol-dissolved oxygen electrochemiluminescence for interferon-γ immunosensing.

Mucosal regulatory and effector T-cell imbalance in CVID-associated enteropathy.

Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling.

What a negative trial does not tell us: Bayesian reanalysis of the enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients randomized clinical trial.

Related Experiment Videos

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'

Related Concept Videos

Related Articles